Compare Enseval Putera Megatrading Tbk. (EPMT) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enseval Putera Megatrading Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Enseval Putera Megatrading Tbk. trades at Rp2,540 (market cap 6.47T, 761.1K 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Enseval Putera Megatrading Tbk. is far larger — about 62× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| EPMT | SCPI | |
|---|---|---|
Market Cap | 6.47T | 104.4B |
Volume | 761.1K | — |
Lot | 7.61K | — |
Turnover | 1.99B | — |
Average Price | 2,611 | — |
Value | 1.99B | — |
Indicative Equilibrium Price | 2,540 | — |
Indicative Equilibrium Volume | 65 | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Enseval Putera Megatrading Tbk.
PT. Enseval Putera Megatrading Tbk, formerly PT Arya Gupta Cempaka, was established based on deed No. 64 dated October 26, 1998 of Mrs. Rukmasanti Hardjasatya,SH, notary public in Jakarta. The company’s articles of association have been amended several times, most recently by deed No. 200 dated June 30, 1997 of Mrs. Poerbaningsih Adi Warsito, SH, notary public in Jakarta, concerning the changes of the company’s articles of association to comply with Corporate Law no. 1 year 1995, the increase in the company’s authorized capital and the change in par value per share from Rp 1,000 to Rp 500.
Read more on EPMT →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
